|
Delayed
Hong Kong S.E.
11:46:02 19/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 8.215 HKD | +2.88% |
|
-2.03% | -2.43% |
| 08:45am | CGS International Adjusts CSPC Pharmaceutical Group's Price Target to HK$11.02 | MT |
| 08:44am | UOB Kay Hian Adjusts CSPC Pharmaceutical Group's Price Target to HK$10 | MT |
Company Valuation: CSPC Pharmaceutical Group Limited
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,00,932 | 97,707 | 86,022 | 55,169 | 96,380 | 91,157 | - | - |
| Change | - | -3.19% | -11.96% | -35.87% | 74.7% | -5.42% | - | - |
| Enterprise Value (EV) 1 | 89,633 | 86,241 | 72,284 | 46,931 | 86,710 | 81,446 | 76,792 | 73,621 |
| Change | - | -3.79% | -16.18% | -35.07% | 84.76% | -6.07% | -5.71% | -4.13% |
| P/E | 14.7x | 14.1x | 13.5x | 12.1x | 21.8x | 8.94x | 13.2x | 12.4x |
| PBR | 3.17x | 2.86x | 2.39x | 1.62x | 2.56x | 2.05x | 1.88x | 1.73x |
| PEG | - | 14.13x | -1.73x | -0.5x | -9.88x | 0x | -0.4x | 1.85x |
| Capitalization / Revenue | 2.94x | 2.77x | 2.52x | 1.78x | 3.26x | 2.34x | 2.53x | 2.37x |
| EV / Revenue | 2.61x | 2.44x | 2.12x | 1.51x | 2.94x | 2.09x | 2.13x | 1.92x |
| EV / EBITDA | 9.5x | 9.43x | 8.39x | 6.22x | 12.1x | 6.68x | 8.05x | 7.36x |
| EV / EBIT | 10.7x | 10.8x | 9.77x | 7.68x | 15.6x | 7x | 9.43x | 8.61x |
| EV / FCF | 23.7x | 14.1x | 26.2x | 17.5x | 19.5x | 10.8x | 12.6x | 12.1x |
| FCF Yield | 4.22% | 7.11% | 3.82% | 5.71% | 5.12% | 9.3% | 7.94% | 8.24% |
| Dividend per Share 2 | 0.18 | 0.21 | 0.28 | 0.26 | 0.29 | 0.4799 | 0.3698 | 0.393 |
| Rate of return | 2.13% | 2.56% | 3.86% | 5.44% | 3.44% | 6.01% | 4.63% | 4.92% |
| EPS 2 | 0.5773 | 0.5831 | 0.5376 | 0.3946 | 0.3859 | 0.8933 | 0.6044 | 0.6449 |
| Distribution rate | 31.2% | 36% | 52.1% | 65.9% | 75.2% | 53.7% | 61.2% | 60.9% |
| Net sales 1 | 34,309 | 35,292 | 34,175 | 31,046 | 29,533 | 39,001 | 35,987 | 38,385 |
| EBITDA 1 | 9,431 | 9,148 | 8,615 | 7,547 | 7,168 | 12,192 | 9,535 | 9,998 |
| EBIT 1 | 8,366 | 7,952 | 7,400 | 6,113 | 5,564 | 11,634 | 8,141 | 8,552 |
| Net income 1 | 6,901 | 6,949 | 6,382 | 4,632 | 4,409 | 10,265 | 7,036 | 7,533 |
| Net Debt 1 | -11,298 | -11,467 | -13,738 | -8,238 | -9,670 | -9,711 | -14,365 | -17,536 |
| Reference price 2 | 8.470 | 8.200 | 7.260 | 4.780 | 8.430 | 7.985 | 7.985 | 7.985 |
| Nbr of stocks (in thousands) | 1,19,16,370 | 1,19,15,520 | 1,18,48,756 | 1,15,41,665 | 1,14,33,025 | 1,14,16,025 | - | - |
| Announcement Date | 22/03/22 | 22/03/23 | 20/03/24 | 28/03/25 | 25/03/26 | - | - | - |
1HKD in Million2HKD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 8.95x | 2.05x | 5.72x | 5.83% | 1.16TCr | ||
| 41.43x | 14.03x | 29.73x | 0.48% | 1,23200Cr | ||
| 40.79x | 6.85x | 19.26x | 1.91% | 66TCr | ||
| 37.33x | 8.57x | 17.72x | 2.36% | 51TCr | ||
| 21.83x | 5.29x | 13.24x | 2.47% | 38TCr | ||
| 101.76x | 5.82x | 24.8x | 2.37% | 34TCr | ||
| 23.99x | 5.78x | 14.05x | 2.75% | 29TCr | ||
| 23.93x | 4.79x | 13.46x | 1.83% | 28TCr | ||
| 23.64x | 7.27x | 13.36x | 2.2% | 24TCr | ||
| -40.04x | 7.4x | 46.61x | 1.94% | 21TCr | ||
| Average | 28.36x | 6.78x | 19.80x | 2.41% | 41TCr | |
| Weighted average by Cap. | 36.32x | 8.79x | 22.32x | 1.71% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 1093 Stock
- Valuation CSPC Pharmaceutical Group Limited
Select your edition
All financial news and data tailored to specific country editions
















